Results: 1 to 50 of 17098
7.
Peroxisome proliferator-activated receptor-gamma agonists suppress iNOS expression induced by LPS in rat primary Schwann cells.
Zhang F, Liu F, Yan M, Ji H, Hu L, Li X, Qian J, He X, Zhang L, Shen A, Cheng C.
J Neuroimmunol. 2009 Nov 24. [Epub ahead of print]PMID: 19942298 [PubMed - as supplied by publisher]
32.
Relations between strain and gender dependencies of irinotecan toxicity and UGT1A1, CES2 and TOP1 expressions in mice.
Ahowesso C, Piccolo E, Li XM, Dulong S, Hossard V, La Sorda R, Filipski E, Tinari N, Delaunay F, Iacobelli S, Lévi F.
Toxicol Lett. 2009 Nov 18. [Epub ahead of print]PMID: 19931604 [PubMed - as supplied by publisher]
38.
Experiment on the factors for enhancing the susceptibility of cancer cells to chemotherapeutic drug by ultrasound microbubbles.
Zhao YZ, Gao HS, Zhou ZC, Tang QQ, Lu CT, Jin Z, Tian JL, Xu YY, Tian XQ, Wang L, Kong FL, Li XK, Huang PT, He HL, Wu Y.
J Drug Target. 2009 Nov 24. [Epub ahead of print]PMID: 19929650 [PubMed - as supplied by publisher]
40.
A novel composite drug delivery system: honokiol nanoparticles in thermosensitive hydrogel based on chitosan.
Li X, Zheng X, Wei X, Guo G, Gou M, Gong C, Wang X, Dai M, Chen L, Wei Y, Qian Z.
J Nanosci Nanotechnol. 2009 Aug;9(8):4586-92.PMID: 19928122 [PubMed - in process]